Psychiatry and Neurology, Neurology · Cherry Hill, NJ
NPI
1902818610
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1210 Brace Rd, Suite 100
Cherry Hill, NJ, 08034
Phone (856) 342-2445
Groups this clinician bills Medicare through
Medicare paid, 2024
$35K
1,137 services
Medicare patients, 2024
141
Average age 74
Drug cost, 2024
$1.3M
1,947 prescriptions
Company payments, 2025
$2,122
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Andrew J McGarry was code 99215 (office e&m - established), 177 times for 114 patients. In total Andrew J McGarry billed 1,137 services in 11 codes, and Medicare paid $35K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-11-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 177 | 114 | $137.47 | $24K |
| 99205 Office E&M - New | Office | 24 | 24 | $145.18 | $3,484 |
By year: 2022 $42K for 1,383 services; 2023 $35K for 473 services; 2024 $35K for 1,137 services.
Medicare prescription drug claims, 2024
In 2024, the drug Andrew J McGarry prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 511 prescriptions and refills. In total Andrew J McGarry wrote 1,947 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 511 | 1,251 | 131 | $22K |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 168 | 400 | 37 | $8,276 |
| Gabapentin Generic | 109 | 259 | 31 | $1,990 |
| Clonazepam Generic | 98 | 247 | 32 | $1,198 |
| Ropinirole Hcl Generic | 96 | 258 | 24 | $3,401 |
| Ropinirole Er Ropinirole Hcl | 86 | 214 | 25 | $16K |
| Rytary Carbidopa/Levodopa | 83 | 160 | 15 | $171K |
| Primidone Generic | 72 | 187 | 18 | $2,010 |
| Neupro Rotigotine | 68 | 131 | 16 | $104K |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 64 | 150 | 16 | $1,416 |
| Amantadine Amantadine Hcl | 57 | 169 | 15 | $3,919 |
| Rasagiline Mesylate Generic | 49 | 147 | 13 | $14K |
| Nuplazid Pimavanserin Tartrate | 47 | 51 | Under 11 | $248K |
| Nourianz Istradefylline | 46 | 76 | Under 11 | $144K |
| Propranolol Hcl Er Propranolol Hcl | 33 | 99 | 12 | $1,985 |
Brand drugs: 325 claims; generic drugs: 1,622 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Andrew J McGarry $2,122 ($122 in general payments such as food, travel and fees and $2,000 for research) from 5 companies. The largest payer was Ipsen Innovation with $2,000.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.